cv 6209 has been researched along with Circulatory Collapse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuoka, T | 1 |
| Fukuoka, T; Hisanaga, M; Kanehiro, H; Matsumoto, M; Nakajima, Y; Nakano, H; Segawa, M; Wada, T | 1 |
2 other study(ies) available for cv 6209 and Circulatory Collapse
| Article | Year |
|---|---|
[An experimental study on shock after temporary hepatic inflow occlusion and platelet activating factor (PAF)].
Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Constriction; Liver; Male; Mitochondria; Platelet Activating Factor; Portasystemic Shunt, Surgical; Pyridinium Compounds; Rats; Rats, Inbred Strains; Shock | 1990 |
Effect of a platelet activating factor antagonist (CV6209) on shock caused by temporary hepatic inflow occlusion.
Topics: Analysis of Variance; Animals; Blood Pressure; Hypotension; Ligation; Liver; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Shock | 1990 |